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Abstract
Background: The genome of the apicomplexan parasite Cystoisospora suis (syn. Isospora suis) has recently been
sequenced and annotated, opening the possibility for the identification of novel therapeutic targets against
cystoisosporosis. It was previously proposed that a 42 kDa uncharacterized merozoite protein, encoded by gene
CSUI_005805, might be a relevant vaccine candidate due to its high immunogenic score, high expression level
and species-specificity as determined in silico.
Methods: The 1170 bp coding sequence of the CSUI_005805 gene was PCR amplified and cloned into the
bacterial expression vector pQE-31. The specificity of the expressed recombinant protein was evaluated in an
immunoblot, and relative levels of expression in different developmental stages and subcellular localization were
determined by quantitative real-time PCR and indirect immunofluorescence assay, respectively.
Results: The CSUI_005805 gene encoded for a 389 amino acid protein containing a histidine-rich region. Quantitative
RT-PCR showed that CSUI_005805 was differentially expressed during the early development of C. suis in vitro, with
higher transcript levels in merozoites compared to sporozoites. The recombinant protein was specifically recognized
by sera from chicken immunized with recombinant CSUI_005805 protein and sera from piglets experimentally
infected with C. suis, all of which suggested that despite prokaryotic expression, the recombinant CSUI_005805
protein maintained antigenic determinants and could elicit an immune response in the host. Immunofluorescence
labelling and confocal microscopy revealed localization primarily at the surface of the parasite.
Conclusions: The results suggest that CSUI_005805 is highly expressed in merozoites and might thus be critical for
their survival and establishment inside host cells. Owing to its specificity, localization and expression pattern, CSUI_
005805 could be exploited as an attractive candidate for alternative control strategies against C. suis such as vaccines.
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Background
Cystoisospora suis (syn. Isospora suis), an enteric proto-
zoan parasite of swine, is a member of the phylum
Apicomplexa and the causative agent of neonatal por-
cine coccidiosis (cystoisosporosis). It is distributed
worldwide with high prevalence rates in intensive pig
breeding facilities regardless of the farm management
system [1, 2]. Suckling piglets in the first 3 weeks of life
are most prone to clinical disease, whereas the infection
is usually asymptomatic in older piglets with little or no
oocyst excretion [3, 4]. Cystoisospora suis has a direct
life-cycle with faecal-oral transmission that facilitates its
rapid spread among and between litter-mates [5]. Upon
ingestion, sporulated oocysts undergo excystation and
sporozoites then invade enterocytes to develop into mer-
ozoites [6] followed by gamonts [7, 8]. Infected piglets
show watery to pasty non-hemorrhagic diarrhea [1],
weight loss and uneven weaning weight [9–11] leading
to significant economic losses for pig breeders [12, 13].
In the European Union, control of cystoisosporosis
can currently be accomplished by metaphylactic medica-
tion with toltrazuril which is highly effective [11, 12, 14,
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15]. However, emerging resistance is of concern as sev-
eral incidences of drug resistance against anticoccidials
including toltrazuril have already been reported in
Eimeria of poultry [16, 17], which, along with legislative
restrictions on the use of anticoccidials in many coun-
tries and increasing consumers’ interest in drug residue-
free animal products, has led to an urge for development
of alternative intervention strategies.
Live, virulent vaccines in large amounts, are impracti-
cal for the use in swine as even low infection doses can
lead to disease in very young piglets [18], and attenuated
lines have not yet been introduced for C. suis. An alter-
native approach would be the introduction of subunit or
recombinant vaccines, which demands a systematic
search for antigenic proteins to find appropriate vaccine
candidates for testing.
The identification of protective antigens is vital for the
development of any modern vaccine. In the closely re-
lated genus Eimeria, several attempts have been made to
identify and characterize antigen-coding transcripts from
relevant developmental stages [19–26]. The genome of
C. suis has recently been sequenced and contains more
than 11,000 protein-coding genes, most of which are
expressed in merozoites. However, the functional anno-
tation of coding sequences is still a major challenge.
Indeed, more than 40% of the C. suis genes are currently
categorized as of unknown function or annotated as
“uncharacterized hypothetical proteins” [27]. The genes
with unknown function that are considered unique to C.
suis may be the most relevant ones to investigate as
specific targets for recombinant vaccine development.
In a previous study, 399 (34%) of the 1168 potential
vaccine candidates identified by screening of the pre-
dicted C. suis proteome also had no annotated function
[27]. Homology-based searches indicated that a highly
expressed protein of merozoites, encoded by the gene
CSUI_005805 and with unknown function, also lacks
orthologs in other organisms, making it an attractive tar-
get candidate for further research. In the current study,
the complete coding region of the CSUI_005805 gene,
encoding a novel C. suis specific protein, was cloned,
expressed in E. coli and characterized in vitro. To date,
this is the first attempt to identify and characterize a
species-specific antigenic protein of C. suis. Based on
immunolocalization and expression pattern of tran-
scripts, it is suggested that this protein may be import-
ant for the growth and proliferation of merozoites inside
host cells.
Methods
In vitro culture and parasite harvest
Merozoites of C. suis were maintained in intestinal
porcine epithelial cells (IPEC-J2) as described elsewhere
[28]. Free merozoites were harvested by collecting
supernatant of the culture medium 5–6 days post-
infection (p.i.), washed with phosphate buffer saline
(PBS) and purified using a Percoll® density gradient. Fur-
ther, merozoites were filtered through Partec CellTrics®
disposable filters (50 μm), washed twice with PBS and
pelleted by centrifugation at 1000× g for 10 min. Purified
merozoites were snap frozen in liquid nitrogen and
stored at -80 °C until further use.
Crude merozoite lysate preparation
Crude lysate of purified merozoites in PBS was prepared
by rapid freeze-thawing using liquid nitrogen followed
by disruption in a TissueLyser II (Qiagen, Hilden,
Germany). The preparation was then centrifuged at
20,000× g for 10 min at 4 °C to separate soluble and in-
soluble fractions. The insoluble fraction was dissolved
separately in buffer with urea (7 M urea, 2 M thiuourea,
4% 3-((3-cholamidopropyl) dimethylammonio)-1-propa-
nesulfonate, 1% (w/v) dithiothreitol, 20 mM Tris). Pro-
tein concentration was determined by a Bradford assay
[29] using serial dilutions of bovine serum albumin
(BSA) as a standard.
Total RNA extraction and cDNA synthesis
Total RNA was extracted from 4 × 106 purified merozo-
ites using a QIAamp® RNA blood mini kit (Qiagen, Hil-
den, Germany). The RNA preparations were additionally
treated with RNase-Free DNase (Qiagen) for 15 min at
room temperature according to the manufacturer’s in-
structions to remove any traces of DNA. Total RNA was
quantified using a NanoDrop® 2000 (Thermo Fischer Sci-
entific, Waltham, MA, USA) and the integrity was
assessed by electrophoresis on a 1% agarose gel contain-
ing ethidium bromide. cDNA was then synthesized from
the total RNA using an iScript™ cDNA synthesis kit
(BioRad, Hercules, CA, USA).
Molecular cloning of CSUI_005805 full length cDNA
The complete coding region of gene CSUI_005805
(1170 bp) (Additional file 1) was obtained by polymerase
chain reaction (PCR) amplification using gene-specific
primers (forward: 5′-cGA GCT CAA TAC GTC CGG
CGT GAA AAT GT-3′; reverse: 5′-gcG TCG ACC TAT
AGG AGT TCC ACT AAG GTT-3′). Unique restriction
endonuclease recognition sites (bold and italics) were in-
cluded at the 5′-termini of the primers to facilitate the
directional cloning. The target sequence was amplified
under the following conditions: an initial denaturation
step at 95 °C for 5 min; followed by 40 cycles of 94 °C
for 15 s, 64 °C for 1 min, 72 °C for 1.5 min and a final
elongation step at 72 °C for 10 min. Amplification prod-
ucts were loaded onto a 1% agarose gel stained with eth-
idium bromide to determine the size of the amplified
products.
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The amplicons were gel purified using a QIAquick® gel
extraction kit (Qiagen), ligated into the pDrive® cloning vec-
tor (Qiagen), and then used to transform competent Qia-
gen EZ Escherichia coli cells (Qiagen). The resultant
transformants were selected on a Luria-Bertani agar plate
supplemented with 100 μg/ml ampicillin (Sigma-Aldrich, St
Louis, MO, USA) for resistance and 50 μM 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (Sigma) and 80 μg/
ml isopropyl-1-thio-β-D-galactopyranoside (IPTG) (Sigma)
for blue/white screening. Six recombinant (white) clones
were selected and tested by colony PCR using vector-
specific primers. To confirm the integrity of the coding
sequences, recombinant plasmids pDRIVE-CSUI_
005805 were purified using QIAprep® spin miniprep
kit (Qiagen) and sequenced (Microsynth Austria
GmbH, Vienna, Austria) using vector-specific primers.
Sequence analysis of CSUI_005805
The sequences obtained for the CSUI_005805 cDNA
were analyzed for similarity using BLAST programs
at NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and
ToxoDB (http://toxodb.org/toxo/showQuestion.do?ques-
tionFullName=UniversalQuestions.UnifiedBlast). The de-
duced amino acid sequence was obtained using the
open reading frame (ORF) finder at NCBI (https://
www.ncbi.nlm.nih.gov/orffinder/). The molecular mass,
instability index and theoretical isoelectric point were ob-
tained using the ProtParam tool of the ExPASy server of
the Swiss Institute of Bioinformatics (http://web.expa-
sy.org/protparam/). Signal peptides, transmembrane re-
gions, subcellular localization and protein motifs were
predicted using SignalP (http://www.cbs.dtu.dk/services/
SignalP/), Phobius (http://phobius.sbc.su.se/), Predict-
Protein (https://www.predictprotein.org/) and Motifscan
(http://myhits.isb-sib.ch/cgi-bin/motif_scan) computational
tools, respectively.
CSUI_005805 transcription at different time-points of C.
suis development in vitro
Real-time quantitative PCR (qPCR) was used to quantify
CSUI_005805 transcripts at different time-points of the
C. suis development in vitro, namely in free sporozoites
released from sporulated oocysts, intracellular merozo-
ites on days 1, 3 and 6 p.i. and extracellular merozoites
released into the medium on days 5–6 p.i. Total RNA
was extracted from parasites or infected cell cultures at
each time-point using an RNeasy® mini kit (Qiagen) and
treated with RNase-free DNase (Qiagen) to remove any
DNA contamination. First-strand cDNA templates were
synthesized from 1 μg of total RNA using an iScript™
cDNA synthesis kit as described above. Quantitative
PCR amplification of cDNA from each time-point of in
vitro development was carried out in a Mx3000P ther-
mal cycler (Agilent Technologies, Santa Clara, CA,
USA) employing forward and reverse primers (200 nM
each; see Table 1 for details) and 1× SsoAdvanced™ uni-
versal SYBR® Green supermix (BioRad, Hercules, CA,
USA) in a total volume of 20 μl using following cycling
conditions: initial separation of DNA strands at 95 °C
for 30 s, followed by 40 cycles of 95 °C for 15 s, 60 °C
for 30 s, and 72 °C for 30 s, and one cycle of 95 °C for
30 s, 60 °C of 30 s, and 95 °C for 30 s for melting-curve
analysis. Each sample was run in triplicate and the
complete experiment was performed in two separate
biological replicates. The qPCR results were normalized
against each of the four reference genes, namely
glyceraldehyde-3-phosphate, actin, 18S ribosomal RNA
and large subunit ribosomal RNA genes. Average gene
expression relative to the endogenous control for each sam-
ple was calculated using the 2−ΔΔCt method described by
Livak & Schmittgen [30]. Primers for CSUI_005805 gene
and four reference genes (Table 1) were designed using Pri-
mer3Plus software (http://www.bioinformatics.nl/cgi-bin/
primer3plus/primer3plus.cgi/).
Expression and purification of the recombinant
CSUI_005805 protein
The plasmid pDRIVE-CSUI_005805 with correct sequence
and orientation was digested with the restriction enzymes
SacI and SalI. The target fragment was then purified, li-
gated into the expression vector pQE-31 (Qiagen) digested
by the same restriction enzymes, and used to transform
competent E. coli M15 pREP4 cells (Qiagen) for protein ex-
pression. Appropriate target and correct orientation of the
inserts were confirmed by colony PCR, restriction analysis
and sequencing using pQE vector specific primers. The re-
combinant protein expression by E. coli clones was induced
by adding IPTG (final concentration 1 mM) after the
Table 1 Oligonucleotide primers used for qPCR to determine stage-dependent transcription of CSUI_005805
Gene name Forward primer sequence 5′-3′ Reverse primer sequence 5′- 3′ Amplicon length (bp)
GAPDH ATTGGTCGTCTCGTGTTCCG GATCGCACTTGGCTCCTTCT 216
ACT CTTGCTGGCCGTGATTTGAC ATATTGCCGTCCGGAAGCTC 203
18S rRNA GCCAGTAGTCATATGCTTGTC CTAATAAACACTGCCCTTCCTG 195
LSU rRNA TGATTCCGAAGAGTGAGGC CCAGGCGAAACTATAAAGCAG 195
CSUI_005805 CCTGAAAGTCGCCTGTCCAT GACGCGTCAGCCGTTATAGT 224
GAPDH Glyceraldehyde-3-phosphate, ACT Actin, 18S rRNA 18S ribosomal RNA, LSU rRNA Large subunit ribosomal RNA
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OD600 of the culture reached 0.6. The induced bacterial
cells were incubated at 37 °C for 1 h after adding IPTG and
then harvested by centrifugation. Cell pellets were lysed in
lysis buffer (100 mM NaH2PO4, 10 mM Tris-Cl, 8 M urea,
pH 8.0) containing ProteoGuard™ EDTA-Free Protease
Inhibitor Cocktail (Clontech, Mountain View, CA, USA)
followed by sonication (65%, 60 s) and incubation under
constant vortexing for 30 min at room temperature. Next,
the lysate was separated by SDS-PAGE on a 12% gel and
visualized after staining with silver nitrate. The
recombinant (His)6 tagged CSUI_005805 proteins (rCSUI_
005805) were purified from the soluble fraction of lysates
by Ni2+-nitrilotriacetic acid (Ni-NTA) chromatography
[NiNTA spin columns (Qiagen) for small expression cul-
ture and NiNTA agarose (Qiagen) for standard expression
culture], as described in the protocols outlined in the QIA
expressionist handbook for high-level expression and purifi-
cation of (His)6 tagged proteins (https://www.qiagen.com/
at/resources/resourcedetail?id=79ca2f7d-42fe-4d62-8676-4
cfa948c9435&lang=en; June 2003). Protein purity was visu-
alized on a 12% SDS-PAGE gel by silver staining and the
concentration was measured by a Bradford assay as de-
scribed before. The purified protein was stored in aliquots
at -20 °C until used.
Mass spectrometry
The protein bands corresponding to rCSUI_005805 were
manually excised from silver stained SDS-PAGE gels and
subsequently digested in-gel using trypsin (Trypsin Gold,
Mass Spectrometry Grade, Mannheim, Germany). The
extracted peptides were then subjected to protein
identification and quantification using a high-resolution
quadrupole time of flight mass spectrometer (Triple
TOF 5600+, AB Sciex, Foster City, CA, USA) coupled to
a nano-HPLC Ultimate 3000 RSLC system (Dionex,
Amsterdam, The Netherlands). The processed MS spec-
tra were searched against UniProt DB (downloaded from
the publicly available UniProt server (www.uniprot.org))
together with the in-house generated C. suis database.
Anti-rCSUI_005805 monospecific polyclonal serum
production
Seven-week-old specific pathogen-free (SPF) white leghorn
chicken (n = 10) were immunized intramuscularly three
times at 2-week intervals with purified rCSUI_005805.
Primary immunization was performed with 0.1 mg of puri-
fied rCSUI_005805 in Freund’s complete adjuvant (Sigma-
Aldrich) as a 1:1 emulsion. The birds were boostered twice
with the same amount of purified rCSUI_005805 in
Freund’s incomplete adjuvant (Sigma-Aldrich). Two weeks
after the final booster immunization, birds were bled for
collection of serum (chicken anti-rCSUI_005805 polyclonal
sera). Sera collected before immunization was used as
negative control sera (pre-immune chicken sera).
Immunoblot analysis of rCSUI_005805 and crude
merozoite lysate
Crude protein lysate from purified merozoites and
rCSUI_005805 was subjected to SDS-PAGE on a 12%
gel and the resolved protein bands were visualized using
silver nitrate. The protein bands from the unstained
gels were transferred to nitrocellulose (NC) mem-
branes (BioRad) for immunoblot. After blocking for
1 h with 2% BSA in PBS at room temperature, the
NC membranes were incubated with anti-His horse-
radish peroxidase (HRP) conjugates (Qiagen), chicken
anti-rCSUI_005805 polyclonal sera (dilution, 1:200),
highly positive porcine anti-C. suis polyclonal sera
from experimentally infected piglets (dilution, 1:200)
[31, 32] or the negative chicken sera (dilution, 1:200)
diluted in TTBS buffer (100 mM Tris, 0.9% NaCl,
0.1% Tween 20) for 30 min at room temperature. To
test cross-reactivity of naïve and recombinant anti-
genic proteins of C. suis to Eimeria spp., the NC
membranes were incubated separately with field sera
obtained from chickens that had been vaccinated with
HIPRACOX® (HIPRA, Amer, Spain). After rinsing in
TTBS for 15 min, blots were exposed to biotinylated
goat anti-pig IgG (dilution, 1:400) or biotinylated goat
anti-chicken IgY (dilution, 1:300) (Vector Laborator-
ies, Burlingame, CA, USA) diluted in TTBS buffer as
secondary antibody for 30 min at room temperature,
incubated with avidin-biotin complex solution (Vector
Laboratories) and finally detected by 3,3′-5,5′-tetra-
methylbenzidine, according to the manufacturer’s
instructions.
Immunofluorescence analysis
Purified extracellular merozoites and sporozoites
were transferred to poly-L-lysine treated glass slides
(Polysciences Inc., Hirschberg an der Bergstrasse,
Germany) and air dried before fixation. Parasites
were either fixed with 4% paraformaldehyde in PBS
for 10 min followed by permeabilization with 0.25%
TritonX-100 in PBS for 10 min or fixed in ice-cold
100% methanol for 10 min and then blocked with
4% BSA in PBS for 2 h at room temperature. A 1:50
dilution of chicken anti-rCSUI_005805 polyclonal
sera was added and incubated for 2 h at room
temperature followed by 1 h incubation with a 1:300
dilution of Alexa Fluor® (A488) goat anti-chicken
IgG (Invitrogen, Eugene, OR, USA). Nuclei were vi-
sualized by staining with 1 μg/ml of 4,6-diamidino-
2-phenylindole (DAPI) (Sigma-Aldrich) for 5 min
prior to mounting under coverslips with Aqua-Poly/
Mount (Polysciences Inc.). The slides were washed
five times with PBS for 25 min after each step
described above. Imaging was done on a Zeiss Axio
Imager Z2 wide-field fluorescence microscope (×63 oil
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immersion objective) and a Zeiss LSM 510 Meta-confocal
laser scanning microscope (×63 oil immersion objective).
Images were analyzed with Light Editions of Zen
2012 and 2009 (Carl Zeiss Microimaging GmbH, Jena,
Germany).
Inhibition of host-cell invasion in vitro
A qPCR assay was developed in combination with in
vitro culture to determine efficacy of the inhibition of
host-cell invasion by sporozoites. IPEC-J1 cells (1.5 × 105
cells/well) were seeded in 12-well plates (TPP, Trasadin-
gen, Switzerland) and cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM-Ham’s F12) (Gibco, Grand Is-
land, NY, USA) supplemented with 5% fetal calf serum,
2 mM L-glutamine, 100 U/ml penicillin and 0.1 mg/ml
streptomycin (Gibco) at 37 °C with 5% CO2 for 24 h.
Freshly-excysted sporozoites were counted and pre-
incubated at 37 °C with different concentrations of ei-
ther chicken anti-rCSUI_005805 or porcine anti-C. suis
polyclonal sera for 2 h. The corresponding concentra-
tions of pre-immune chicken serum or previously
collected pre-colostral piglet serum [31, 32] were used
as a negative controls and equivalent volumes of
complete DMEM-Ham’s F12 medium as a baseline con-
trol. Pre-incubated sporozoites (2 × 103/well) were used
to infect IPEC-J1 cells and the cells were allowed to
grow at 40 °C with 5% CO2 for 24 h. Cultures were then
washed four times with PBS and subjected to DNA ex-
traction using a peqGOLD Microspin Tissue DNA Kit
(peqlab, Erlangen, Germany), according to the manufac-
turer’s instructions. The DNA was eluted with 75 μl of
elution buffer and subjected to qPCR for C. suis genome
quantification using the large subunit rRNA gene (LSU
rRNA gene) as target (GenBank accession number:
AF093428.1). qPCR was performed in a Mx3000P ther-
mal cycler (Agilent Technologies, Santa Clara, CA,
USA) using 400 nM of each primer (forward: 5′-TGA
TTC CGA AGA GTG AGG C -3′; reverse: 5′-CCA
GGC GAA ACT ATA AAG CAG -3′), 200 nM probe
(5′- FAM-TCC GGC ATT GAT CCC TCT GCT TTA
TCC C-BHQ1-3′) and 5 μl undiluted template DNA
with SsoAdvanced™ Universal Probes Supermix
(BioRad). Each sample was run in triplicate and the
experiment was performed twice under the following
cycling conditions: 95 °C for 10 min followed by 40 -
cycles with 95 °C for 30 s and 60 °C for 1 min. In
vitro inhibition percentage for each culture was calcu-
lated as follows:
The differences among experimental groups were
tested by one-way ANOVA using Microsoft Excel 2007,
with significance reported at P < 0.05.
Results
Cloning and sequence analysis
The CSUI_005805 gene included a 302 bp 5′-untrans-
lated region (5′-UTR) before the ATG initiation codon
and a 1170 bp coding sequence terminating with the
TAG stop codon (Fig. 1), followed by a 44 bp 3′-UTR. A
single 1170 bp CSUI_005805 ORF encoded a protein of
389 amino acids with the predicted molecular mass of
42 kDa. The theoretical isoelectric point and instability
index were 5.52 and 47.77, respectively. The deduced
amino acid sequence had a predicted N-terminal 19-
amino acids signal peptide (1–26) for entrance into the
secretory pathway, and it also had two predicted trans-
membrane domains (TM1:91–109; TM2:152–171) in the
C-terminal region of the protein that could serve as
membrane anchorage (Fig. 2). However, it had no identi-
fiable homology to known proteins that might allude to
its function. Motifscan predicted two putative glycosyla-
tion sites and four putative protein kinase C phosphoryl-
ation sites (Fig. 1).
Real-time quantitative PCR analysis of CSUI_005805
transcripts
The expression profile of the CSUI_005805 mRNA was
examined at different time-points of C. suis development
in vitro using qPCR. Among the extracellular stages,
CSUI_005805 transcripts in merozoites were 18-fold
higher (Fig. 3a) compared to sporozoites, which agrees
with the high expression level in merozoites measured
from an RNA-Seq experiment [27]. Additionally, the
level of CSUI_005805 transcripts on day 3 and 6 p.i.
were 12- and 21-fold higher, respectively, in intracellular
merozoites compared to that of day 1 p.i. (Fig. 3b).
Expression and purification of rCSUI_005805
The recombinant CSUI_005805 protein (rCSUI_005805)
was expressed in M15 pREP4 E. coli as a His-tagged fu-
sion protein. A PCR product of 1170 bp was purified
from an agarose gel and cloned into a pre-linearized
pQE-31 bacterial expression vector containing N-
terminal (His)6 tag prior to transformation of chemically
competent E. coli M15 pREP4 cells. rCSUI_005805
expressed in bacterial lysate revealed a major protein
band of ~42 kDa after induction with 1 mM IPTG for
% of inhibition ¼ 100  1 ‐ average no: of C: suis gene copies in serum treated cultures






Shrestha et al. Parasites & Vectors  (2017) 10:68 Page 5 of 13
1 h at 37 °C indicating that this was the most appropri-
ate incubation time for expression (Fig. 4a, Lane 3). A
band of the target protein was not detected in the bac-
terial culture that had not been induced with IPTG
(Fig. 4a, Lane 1). To isolate any tagged proteins inde-
pendent of their solubility and location within the cells,
purification of rCSUI_005805 was performed under de-
naturing conditions which allows solubilization of most
proteins and inclusion bodies [33], thereby facilitating
their direct analysis by SDS-PAGE.
Purification of small expression cultures (10 ml) with
NiNTA spin columns after induction with IPTG showed a
major protein band of ~ 42 kDa together with a smaller
protein band of ~ 25 kDa (Fig. 4b, Lanes 1, 2). However,
when the expression was scaled up to 500 ml and was
batch purified using NiNTA agarose with step-wise elu-
tion in elution buffer (100 mM NaH2PO4, 10 mM Tris-Cl,
8 M urea, pH 4.5), SDS-PAGE showed a major protein
band of ~ 25 kDa and only a faint band of ~ 42 kDa
(Fig. 4C, Lanes 1–5). LC-MS/MS analysis of the 25 kDa
band corroborated the presence of a part of the
CSUI_005805-coded protein as deduced by nucleic acid
translation. Additionally, as (His)6 tagged protein, the ex-
pression and characterization of the rCSUI_005805 was
verified by immunoblot analysis with an anti-His HRP con-
jugate (Qiagen), reacting specifically as expected (Fig. 4d).
Fig. 1 The nucleotide sequence and deduced amino acid sequence of complete coding region of CSUI_005805 gene. Vertical arrow, signal
peptide cleavage site; green shaded, start codon; red shaded, stop codon; wavy underlined, putative protein kinase C phosphorylation sites;
underlined, putative N-glycosylation site; gray shaded, histidine rich region
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Immunoblot analysis of rCSUI_005805 and crude
merozoite lysate
The immunoblot of purified rCSUI_005805 probed with
highly positive porcine anti-C. suis polyclonal serum
could detect the expected ~ 25 kDa and ~ 42 kDa protein
bands indicating that bacterially expressed rCSUI_
005805 maintained the antigenic determinants recog-
nized by protective porcine antibodies compared to their
naïve protein counterparts (Fig. 5a, Lane 1). Apart from
these two bands, a lower molecular weight protein band
(~23 kDa) was also detected by porcine anti-C. suis
polyclonal sera, which might represent either (a) de-
graded products, (b) N-terminal proteolytic truncations
of rCSUI_005805, since it was only detected by porcine
anti-C. suis antibodies but not by anti-His HRP conju-
gates that recognize the N-terminal poly-histidine tag on
recombinant proteins or (c) an unrelated antigenic
protein co-purified together with rCSUI_005805. These
bands were not detected when porcine pre-colostral
serum was used (Fig. 5a, Lane 2). Similarly, chicken anti-
rCSUI_005805 polyclonal sera also recognized purified
rCSUI_005805 (~25 kDa) by immunoblotting (Fig. 5b, Lane
2), which confirmed the specificity of the polyclonal sera
produced. No bands were detected when the immunoblots
were probed with negative (pre-immune) chicken sera
(Fig. 5b, Lane 1). Furthermore, to confirm that the chicken
anti-rCSUI_005805 sera did in fact recognize the native
form of CSUI_005805 protein and not a cross-reactive epi-
tope, an analysis was carried out in which crude merozoite
extract was probed with anti-rCSUI_005805 serum. Naïve
protein of 42 kDa in insoluble (Lanes 1–3) and soluble
(Lanes 4–6) fractions of crude merozoite extract were rec-
ognized by chicken anti-rCSUI_005805 polyclonal sera
(Fig. 5c, Lanes 3, 6) in a pattern like those identified by
highly positive porcine anti-C. suis polyclonal sera (Fig. 5c,
Lanes 1, 4). As expected, negative chicken serum also failed
Fig. 2 Schematic representation of predicted transmembrane topology of CSUI_005805 protein. It consists of two transmembrane domains (TM)
with extracellular N and C termini and a long cytoplasmic loop extending between TM1 andTM2
Fig. 3 Relative mRNA expression levels of CSUI_005805 in vitro. a Free sporozoites and merozoites. b Intracellular merozoites on day 1, 3 and 6
post-infection (p.i.). The data are displayed as mean ± standard deviation
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to detect any bands in an immunoblot of naïve merozoite
proteins (Fig. 5c, Lanes 2, 5). None of the antigenic proteins
(naïve or rCSUI_005805) of C. suis were recognized by
serum antibodies from chickens vaccinated with HIPRA-
COX® in an immunoblot (Fig. 5d), indicating that C. suis
does not share common epitopes with avian Eimeria spp.
that are detectable by an immunoblot analysis.
Immunolocalization of CSUI_005805 antigens in
merozoites and sporozoites
Fixed extracellular merozoites and sporozoites were
immune-stained with chicken anti-rCSUI_005805
polyclonal serum, visualized with A488 (green) and
counter-stained with DAPI (red). Immunofluores-
cence based localization studies in merozoites
showed that irrespective of the fixation techniques
used, the labelled antigen was mainly concentrated
towards the surface of merozoites (Fig. 6). In some
cases, staining was observed towards surface, except
for a small gap at the extreme apical and basal ends of
merozoites (Fig. 6e), indicating apparent localization
of rCSUI_005805 with the inner membrane complex
(IMC) [34]. Moreover, the presence of signal peptide and
transmembrane domains suggests that rCSUI_005805
a b c d
Fig. 4 Expression of rCSUI_005805. Lane M: molecular weight marker. a Analysis of expressed recombinant protein by SDS-PAGE: uninduced cul-
ture (Lane 1); induced culture with 1 mM IPTG for 0.5 h (Lane 2) and 1 h (Lane 3), arrows indicate target protein bands of ~42 kDa. b SDS-PAGE
analysis of NiNTA spin column purified rCSUI_005805: elution 1 (Lane 1); elution 2 (Lane 2), arrows indicate faint protein bands of ~25 kDa; naïve
merozoite lysate (Lane 3). c Batch purified rCSUI_005805 using NiNTA agarose: stepwise elution (Lanes 1–5), arrows indicate faint protein bands
of ~42 kDa. d Immunoblot of batch purified rCSUI_005805 probed with anti-His HRP conjugate (Lane 1)
Fig. 5 Immunoblot analyses of rCSUI_005805 and naïve merozoite lysate. The expressed recombinant protein and crude merozoite lysate were
separated by SDS-PAGE and transferred to NC membranes. Lane M: Molecular weight marker (ordinate values describe band sizes in kDa); a Im-
munoblot of rCSUI_005805 probed with porcine anti-C. suis polyclonal sera (Lane 1) and with porcine pre-colostral sera (Lane 2). b Immunoblot
of rCSUI_005805 probed with negative chicken serum (Lane 1) and chicken anti-rCSUI_005805 polyclonal sera (Lane 2). c Immunoblot of insoluble
(Lanes 1–3) and soluble fractions (Lanes 4–6) of naïve merozoite lysate probed with porcine anti-C. suis polyclonal sera (Lanes 1 and 4), chicken
anti-rCSUI_005805 polyclonal sera (Lanes 3 and 6) and negative chicken sera (Lanes 2 and 5), respectively. d Immunoblot of naïve merozoite
lysate (Lanes 1 and 2) and rCSUI_005805 (Lane 3) probed with field sera from chickens vaccinated with HIPRACOX®
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might be synthesized as mature protein in the cytosol
and then transported to the external membrane. The
intensity of A488 fluorescence was much lower in
fixed extracellular sporozoites than that of merozoites
(Fig. 6c). No reactivity was observed when merozoites
were stained with negative chicken serum as a pri-
mary antibody (Fig. 6b).
Serum invasion-inhibition assay
Porcine anti-C. suis and chicken anti-rCSUI_005805
polyclonal sera were tested for their ability to inhibit the
invasion of cultured IPEC-J1 cells in vitro by C. suis spo-
rozoites. The highest serum concentration that could be
employed was 2.5% because higher concentrations lead
to non-specific and non-reproducible results in the assay
a1 a2 a3 a4






Fig. 6 Localization of CSUI_005805 antigens in merozoites and sporozoites. a–c Wide-field epifluorescence microscope (×63 magnification; scale-
bar: 10 μm). d–f Meta confocal laser scanning microscope (×63 magnification; scale-bar: 5 μm). a C. suis merozoites: (a1) Differential interference
contrast (DIC); (a2) Localization using A488; (a3) Nuclear staining with DAPI (a4) DIC, A488 and DAPI merged. b Negative control, merozoites
probed with negative chicken serum: (b1) DIC; (b2) A488; (b3) DAPI; (b4) merged. c C. suis sporozoites: (c1) DIC; (c2) A488; (c3) DAPI; (c4) merged.
d and e Paraformaldehyde-fixed C. suis merozoites: (d1, e1) A488; (d2, e2) DAPI; (d3, e3) merged. f Methanol-fixed C. suis merozoites: (f1) A488;
(f2) DAPI; (f3) merged
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(details not shown). Pre-treatment with positive serum
antibodies decreased the invasion capacity of sporozoites
as determined by evaluating the number of parasite
stages in culture 24 h after infection, and the observed
inhibition effect was dose-dependent. Positive chicken
anti- rCSUI_005805 serum (2.5%) decreased the number
of intracellular stages by 28.3% compared to the baseline
control and by 50.6% compared to the pre-immune
serum of the same concentration. In comparison, 2.5%
positive piglet serum decreased the detected number of
intracellular stages by 62.1% compared to the baseline
and by 74.2% compared to pre-colostral serum of the
same concentration. Similarly, 1.25% positive piglet and
chicken sera decreased the number of detected stages by
18.5 and 6.8%, respectively, compared to the baseline
control and 46.2 and 15.9%, compared to the respective
pre-immune serum. For both chicken and piglet sera,
pretreatment with 2.5 or 1.25% positive sera significantly
decreased (F(1,10) = 13.15, P = 0.004; F(1,10) = 29.42, P =
0.0002, respectively) the invasion capacity of sporozoites
while other concentrations had no inhibiting effects.
Discussion
Cystoisospora suis is an intracellular apicomplexan
parasite that develops entirely in single host [35]. Like
in other coccidia, replicating merozoites and gamonts
are the most pathogenic stages [32, 36, 37], leading to
host cell destruction and thus altering intestinal per-
meability. The global distribution of cystoisosporosis with
high prevalence and limited control options demands
innovation strategies for novel alternative control mea-
sures. The role of humoral immune responses in terms of
conferring protective immunity to coccidial infection is
debatable. However, evidences of protection by parasite-
specific antibodies, either maternally derived or self-
produced, have been reported in Eimeria [38–41] and
recently in C. suis [32]. Protective antibodies might thus
be important for the defense against invasive stages,
sporozoites and merozoites. Cystoisospora suis merozoites
express between 9000 and 10,000 proteins during their de-
velopment [27], thereby exposing the host to a complex
assembly of antigens. Logically, the most reliable and ef-
fective antigens for raising protective immunity against C.
suis would be those that are parasite-specific, highly
expressed and associated with invasion and/or progression
of pathogenesis in the host.
Proteins of unknown function comprise 30–40% of the
total number of proteins annotated from any genome
[42]. In all sequenced coccidian genomes, a large
fraction of the predicted genes encodes for proteins with
no orthologs and/or unknown function [27, 43–46].
These could constitute a rich reservoir for species-
specific antigens and thus putative targets for immune-
intervention. In line with this trend, previous screening
of the predicted proteome of C. suis with the software
Vacceed revealed numerous potential vaccine candidates
with no annotated function [27]. Among these,
CSUI_005805, which encodes for an uncharacterized
protein, appeared to be an attractive candidate owing to
its species-specificity and high expression in merozoites.
In the present study, the entire coding sequence of the
CSUI_005805 gene was cloned and characterized. A sin-
gle CSUI_005805 ORF of 1170 bp encoded for 389
amino acids with a predicted molecular mass of 42 kDa
and contained a predicted signal peptide and two pre-
dicted transmembrane domains. The presence of signal
peptide and transmembrane domains suggest that the
protein enters the secretory pathway and is actively
transported out of the cell to anyone of the numerous
cellular membrane systems [47]. Signal peptides are
found both in secreted and most cell surface proteins
[48], but proteins with predicted signal peptide in com-
bination with transmembrane domains are considered
membrane-spanning [47] and might escape secretion.
Thus, it is likely that CSUI_005805 is a secretory protein
with a signal peptide and/or one or more transmem-
brane domains for membrane anchorage [49]. Previous
studies suggested that most transmembrane proteins
encoded by apicomplexans localize to the external
membrane or IMC rather than organellar membranes
[50–52]. Also, it has recently been reported that in
Plasmodium components of the IMC are surface-
exposed and accessible to antibodies [53], and presum-
ably this might also be the case in C. suis, indicating that
these proteins could be good targets when selecting for
vaccine candidates.
The gene encoding the complete CSUI_005805 protein
was cloned into the bacterial expression vector pQE-31
to express the recombinant protein rCSUI_005805 in a
size similar to the predicted molecular mass that was
present in extracts of the E. coli host as visualized in
SDS-PAGE by silver staining. However, batch purifica-
tion of rCSUI_005805 using NiNTA agarose resulted in
a faint 42 kDa and a major 25 kDa protein band, sug-
gesting that rCSUI_005805 either undergoes proteolytic
maturation yielding smaller 25 kDa protein fragments or
the smaller protein band might be a breakdown product
of rCSUI_005805 during affinity purification. Addition-
ally, LC-MS/MS analysis of this smaller protein band
was consistent with the amino acid sequence predicted
for the CSUI_005805 protein. The observed unstable
nature of rCSUI_005805 is also in agreement with the
predicted instability index value of 47.77 as proteins with
an index > 40 are considered unstable [54].
During expression and purification, rCSUI_005805
maintained a conformation that was recognized by anti-
serum raised against naïve proteins in immunoblotting,
indicating that despite bacterial expression, rCSUI_005805
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retained antigenic and immunogenic properties and could
induce an antibody response in the host. Chicken anti-
rCSUI_005805 antibodies could identify soluble and insol-
uble fractions of naïve merozoite proteins in a pattern
similar to that identified by sera of experimentally infected
piglets, further suggesting that rCSUI_005805 mimics the
antigenic properties elicited by immunization with naïve
antigens.
Identification of genes expressed in various stages of
the life-cycle of a parasite is critical to understand its de-
velopmental biology [55–57] and immunological “bottle-
necks” where it is most vulnerable. Relative expression
patterns of CSUI_005805 mRNA levels at different cul-
tured stages of C. suis showed that CSUI_005805 was
differentially expressed with higher transcription in mer-
ozoites compared to sporozoites. Once the sporozoites
invaded the enterocytes, the transcription level increased
steadily throughout the entire merogony, indicating that
this protein is important for the survival and establish-
ment of merozoites. Expression of CSUI_005805 tran-
scripts in other stages, especially gamonts, should be
investigated to complete the picture.
Chicken anti-rCSUI_005805 polyclonal serum was used
to determine the subcellular localization of the CSUI_
005805 protein in fixed extracellular sporozoites and mero-
zoites. Apart from a slightly diffuse cytoplasmic distribu-
tion, a major proportion localized at the surface of the
parasite, indicating that the investigated protein might be
secreted and then translocated to the external membrane
as indicated by the results of in silico analyses outlined
above. Fixation techniques with either paraformaldehyde or
methanol did not alter the localization pattern of this pro-
tein. In sporozoites fluorescence intensity of A488 was
lower compared to merozoites with both fixation tech-
niques, which supports the results of qPCR that detected
increasing levels of CSUI_005805 transcription during in
vitro cultivation of C. suis as described above.
The ability of apicomplexan parasites to invade host cells
is key to their survival and pathogenesis [58]. Host cell in-
vasion is a complex process and is relatively conserved
among the members of this taxon [59]. Genomic DNA ex-
tracted from parasites after cultivation for 24 h can be used
as a template for quantitatively assessing invasion [60]. Spo-
rozoites pre-incubated with 2.5% anti-rCSUI_005805 anti-
bodies prior to infection of IPEC-J1 cells slightly reduced
the number of intracellular parasites whereas inhibition of
host-cell invasion by porcine anti-C. suis serum antibodies
in the same dilution was two-fold higher, indicating that
CSUI_005805 does not play a leading role in the invasion
of the host-cell, at least not by itself.
Conclusions
We successfully cloned and characterized a novel gene
of C. suis, CSUI_005805, which encodes for a species-
specific, differentially expressed transmembrane protein.
The recombinant CSUI_005805 protein seemed to
undergo proteolytic maturation after purification but
retained the antigenic and immunogenic properties and
is recognized by host antibodies. In vitro expression of
CSUI_005805 transcripts increases steadily as soon as
sporozoites invade IPEC-J1 cells in vitro, indicating that it
might be crucial for establishment and/or growth of mero-
zoites inside the host cells. Currently, no genetic manipu-
lation technique to confirm the direct implication of
CSUI_005805 in parasite development is available for C.
suis. Nevertheless, we have shown that rCSUI_005805
could explicitly induce an antibody response in infected
hosts, and given that humoral immune responses confer
at least partial protection in C. suis, this protein could be
exploited for the development of alternative control strat-
egies, possibly in combination with other complementary
antigens.
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